Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The interface is clean and data-driven, appealing to users who appreciate precision
How Patent Thickets Work and Why Humira Is the Defining Case Study AbbVies 247-Patent Strategy and What It Tells Investors AbbVie filed over 247 patent applications covering adalimumab (Humira) in the U.S
Science 363 , 10881092 (2019)
With lower prices for out-of-pocket purchasing, there might be an opportunity for people to switch over to the actual molecules through the company, Gallagher says
That vaulted it past Merck ($65.01B), Pfizer ($62.58B), and AbbVie ($61.16B) into the No
Some plans may only offer partial cover
US$ 22.48
US$ 23.38
US$ 22.77
US$ 24.13
US$ 20.05
US$ 28.51
